# Germiphene Corporation – FDA Inspection, May 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/germiphene-corporation/48d1d854-5177-4987-888d-a1d1c00f267d
Source feed: FDA_Inspections

> FDA inspection 1056647 of Germiphene Corporation, May 24, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056647
- Company Name: Germiphene Corporation
- Inspection Date: 2018-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 962166 - 2016-02-19
- FDA Inspection 777994 - 2012-03-16
- [FDA Inspection 671773 - 2010-06-24](https://www.keypedia.com/records/fda_inspections/germiphene-corporation/3ef7fcc0-2aa3-4bd4-ba5b-ffb84ea89a95)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/germiphene-corporation/0948a001-b5a0-427e-99f4-5dc3f2c36db9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c